SE506421C2 - Monoklonala antikroppar mot Pseudomonas aeruginosa och beredningar innehållande dessa, testsats innehållande beredningen, samt cellinjer uttryckande antikropparna - Google Patents

Monoklonala antikroppar mot Pseudomonas aeruginosa och beredningar innehållande dessa, testsats innehållande beredningen, samt cellinjer uttryckande antikropparna

Info

Publication number
SE506421C2
SE506421C2 SE8702734A SE8702734A SE506421C2 SE 506421 C2 SE506421 C2 SE 506421C2 SE 8702734 A SE8702734 A SE 8702734A SE 8702734 A SE8702734 A SE 8702734A SE 506421 C2 SE506421 C2 SE 506421C2
Authority
SE
Sweden
Prior art keywords
antibody
antibodies
monoclonal antibody
aeruginosa
pseudomonas aeruginosa
Prior art date
Application number
SE8702734A
Other languages
English (en)
Swedish (sv)
Other versions
SE8702734L (sv
SE8702734D0 (sv
Inventor
Mark E Lostrom
Anthony W Siadak
Mae Joanne Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of SE8702734D0 publication Critical patent/SE8702734D0/xx
Publication of SE8702734L publication Critical patent/SE8702734L/
Publication of SE506421C2 publication Critical patent/SE506421C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8702734A 1986-07-03 1987-07-02 Monoklonala antikroppar mot Pseudomonas aeruginosa och beredningar innehållande dessa, testsats innehållande beredningen, samt cellinjer uttryckande antikropparna SE506421C2 (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US4814387A 1987-05-15 1987-05-15

Publications (3)

Publication Number Publication Date
SE8702734D0 SE8702734D0 (sv) 1987-07-02
SE8702734L SE8702734L (sv) 1988-01-04
SE506421C2 true SE506421C2 (sv) 1997-12-15

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702734A SE506421C2 (sv) 1986-07-03 1987-07-02 Monoklonala antikroppar mot Pseudomonas aeruginosa och beredningar innehållande dessa, testsats innehållande beredningen, samt cellinjer uttryckande antikropparna

Country Status (19)

Country Link
JP (1) JP2639422B2 (fr)
KR (1) KR910002373B1 (fr)
AT (1) AT399885B (fr)
AU (1) AU615162B2 (fr)
BE (1) BE1000743A3 (fr)
CH (1) CH677796A5 (fr)
DE (1) DE3722098C2 (fr)
DK (1) DK172840B1 (fr)
ES (1) ES2013321A6 (fr)
FR (1) FR2601458B1 (fr)
GB (1) GB2192185B (fr)
IE (1) IE60888B1 (fr)
IL (1) IL83047A (fr)
IT (1) IT1221940B (fr)
LU (1) LU86938A1 (fr)
NL (1) NL194961C (fr)
OA (1) OA08629A (fr)
PT (1) PT85247B (fr)
SE (1) SE506421C2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
CA1341375C (fr) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions pour le traitement et la prevention d'infections dues a des bacteries gram negatif, ainsi que leurs methodes d'utilisation
JPH02299594A (ja) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd ヒトモノクローナル抗体およびその製法
AU5525490A (en) * 1989-04-14 1990-11-16 Biocontrol Systems, Incorporated Process and device for detecting a particular motile organism
DE69131861T2 (de) * 1990-01-18 2000-05-18 Cura Nominees Pty Ltd Glykoalkaloide
CA2751433A1 (fr) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Antibiotique en combinaison et therapie antibiotique pour traiter une infection par pseudomonas aeruginosa
EP2542577A1 (fr) * 2010-03-01 2013-01-09 Lostam Biopharmaceuticals Ltd ANTICORPS THÉRAPEUTIQUES AMÉLIORÉS CONTRE PSEUDOMONAS AERUGINOSA À FLAGELLES& xA;

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
AU5991786A (en) * 1985-06-06 1987-01-07 Genetic Systems Corporation Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
EP0211352B1 (fr) * 1985-08-01 1994-03-16 Miles Inc. Anticorps protecteurs contre des déterminants sérotypiques d'antigènes flagellaires
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c

Also Published As

Publication number Publication date
GB8715347D0 (en) 1987-08-05
IL83047A (en) 1992-12-01
NL194961C (nl) 2003-09-02
AU615162B2 (en) 1991-09-26
ES2013321A6 (es) 1990-05-01
OA08629A (en) 1988-11-30
FR2601458A1 (fr) 1988-01-15
SE8702734L (sv) 1988-01-04
IL83047A0 (en) 1987-12-31
DK172840B1 (da) 1999-08-09
AT399885B (de) 1995-08-25
JPS63102697A (ja) 1988-05-07
CH677796A5 (fr) 1991-06-28
BE1000743A3 (fr) 1989-03-28
AU7495887A (en) 1988-01-07
SE8702734D0 (sv) 1987-07-02
NL194961B (nl) 2003-05-01
KR880001815A (ko) 1988-04-27
JP2639422B2 (ja) 1997-08-13
DE3722098C2 (de) 1998-06-04
IE871769L (en) 1988-01-03
GB2192185A (en) 1988-01-06
PT85247B (pt) 1990-06-29
KR910002373B1 (ko) 1991-04-20
DE3722098A1 (de) 1988-03-03
NL8701554A (nl) 1988-02-01
IT1221940B (it) 1990-08-31
DK336687A (da) 1988-01-04
LU86938A1 (fr) 1988-02-02
PT85247A (en) 1987-08-01
DK336687D0 (da) 1987-06-30
IE60888B1 (en) 1994-08-24
ATA168387A (de) 1994-12-15
IT8721163A0 (it) 1987-07-02
GB2192185B (en) 1991-01-16
FR2601458B1 (fr) 1992-08-21

Similar Documents

Publication Publication Date Title
US4196265A (en) Method of producing antibodies
FI111336B (fi) Menetelmä Staphylococcus epidermidis tyyppi I:n polysakkaridiantigeenin sisältävän rokotteen ja antigeeninvastaisen hyperimmunoglobuliinin valmistamiseksi
KR910008361B1 (ko) 슈도모나스 이루지노사 항원형에 대한 교차면역 반응성 및 교차보호성 단일분지계 항체
Halk et al. Production of monoclonal antibodies against three ilarviruses and alfalfa mosaic virus and their use in serotyping
US4834976A (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
CA2015246A1 (fr) Anticorps monoclonaux humains, methode de production et utilisation
NZ219187A (en) Composition and hybridoma relating to monoclonal, antibody or binding fragment reactive with a non core carbohydrate epitope of two bacterial species, one species being either e.coli or an enterobacter species
SE506421C2 (sv) Monoklonala antikroppar mot Pseudomonas aeruginosa och beredningar innehållande dessa, testsats innehållande beredningen, samt cellinjer uttryckande antikropparna
Gustafsson et al. Monoclonal antibodies against group-and type-specific lipopolysaccharide antigens of Vibrio cholerae O: 1
EP0259807B1 (fr) Anticorps monoclonal cytolytique dépendant du complément contre trichomonas vaginalis et son utilisation thérapeutique et diagnostique
JPS63500035A (ja) プソイドモナス　アエルギノサ　外毒素ａに対する保護用ヒトモノクロ−ナル抗体
JP4044733B2 (ja) ベロ毒素ｉｉを認識するヒト型化抗体、および該抗体を産生する細胞株
JPH0213376A (ja) 緑膿菌に対するモノクローナル抗体、ならびにその調製および使用
EP0326148A1 (fr) Anticorps monoclonal humain spécifique à Pseudomonas aeruginosa et lignes de cellules hybrides
RU2010856C1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l., используемый для получения преципитирующих моноклональных антител к jgg человека
KR100506118B1 (ko) 수막염균증 백신 조성물
WO1990011350A1 (fr) Anticorps monoclonal humain reagissant avec le pseudomonas aeruginosa, cellule produisant cet anticorps, procede de production et preparation pharmaceutique
JPH0355106B2 (fr)
JPH0361428B2 (fr)

Legal Events

Date Code Title Description
NUG Patent has lapsed